By 2028, Demand for Electrophysiology Market Size $14.84 Billion at 10.2% CAGR Lead by Atrial Fibrillation (11% CAGR in 2028) Global Analysis by The Insight Partners
June 20, 2022 07:01 ET
|
The Insight Partners
New York, June 20, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Electrophysiology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
June 14, 2022 11:00 ET
|
NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
SPO Global Inc. Discusses Company’s Medical Devices
June 08, 2022 09:00 ET
|
SPO Global Inc.
Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides an in depth discussion of the company’s medical devices. ...
SPO Global Inc. Issues Letter to Shareholders
May 10, 2022 09:27 ET
|
SPO Global Inc.
Shandong, China, May 10, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides a corporate update and letter from CEO Fengyou Lu. Dear...
Edmund Optics® Expands in Response to Rapid Growth
April 28, 2022 09:00 ET
|
Edmund Optics (edmundoptics.com)
BARRINGTON, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Edmund Optics®, a leading global manufacturer and supplier of optical components, has announced the opening of a new facility in Cherry Hill, NJ,...
NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to Date
April 07, 2022 11:00 ET
|
NeuroSigma, Inc.
Double-blind randomized controlled trial of eTNS for pediatric ADHD will enroll up to 150 participants at two sites in London and Southampton NeuroSigma’s Monarch eTNS System and electric patches to...
SPO Global Inc. Announces Partnership Between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group), a subsidiary of Gerbang Medical
March 29, 2022 09:00 ET
|
SPO Global Inc.
Shandong, China, March 29, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today announced a partnership Between Cinuo Traditional Chinese Medicine,...
Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 Today, Thursday, March 24th
March 24, 2022 15:00 ET
|
Clearmind Medicine Inc.
TORONTO, March 24, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTCMKTS: CMNDF) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused on the...
SPO Global Inc. Provides Update on Shandong SPO Medical (Group) Co., Ltd.
March 10, 2022 09:00 ET
|
SPO Global Inc.
Shandong, China, March 10, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today announced an update on its strategic cooperation plan to its...
UAT Group Subsidiary, Ossifix Orthopedics, Javelin Fixation Pin Enters Ortho Market
March 10, 2022 07:00 ET
|
Umbra Applied Technologies Group, Inc.
Tampa, FL , March 10, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) (UAT Group), announced today that its subsidiary, Ossifix Orthopedics has entered into full...